Muhammad Tufail

1.3k total citations · 3 hit papers
57 papers, 608 citations indexed

About

Muhammad Tufail is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Muhammad Tufail has authored 57 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Muhammad Tufail's work include Lung Cancer Diagnosis and Treatment (9 papers), Cancer-related gene regulation (4 papers) and COVID-19 and healthcare impacts (4 papers). Muhammad Tufail is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Cancer-related gene regulation (4 papers) and COVID-19 and healthcare impacts (4 papers). Muhammad Tufail collaborates with scholars based in China, United Kingdom and Pakistan. Muhammad Tufail's co-authors include Canhua Jiang, Ning Li, Changxin Wu, Jia Cui, Caiyun He, Jie Liang, Hong Wu, Yuqi Huang, Md Sadique Hussain and Ning Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, IEEE Access and Molecular Cancer.

In The Last Decade

Muhammad Tufail

48 papers receiving 595 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

2024 161 citations Muhammad Tufail, Canhua Jiang et al. Molecular Cancer profile →
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

2025 26 citations Muhammad Tufail, Canhua Jiang et al. profile →
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence

2025 16 citations Muhammad Tufail, Canhua Jiang et al. Military Medical Research profile →

Peers

Muhammad Tufail

MB

CR

ONCOL

PRM

IMMUN

Tian Ma China

Chee Wai Fhu Singapore

Peiyan Hua China

Jung‐Yu Kan Taiwan

Bo Mu China

Hongxia Lin United States

Xiaonian Cao China

Kyung Hee Koo South Korea

Xiaolong Ma China

Tian Ma China

Muhammad Tufail

266 ×0.8

MB

132 ×0.8

CR

104 ×0.8

ONCOL

67 ×0.9

PRM

52 ×0.9

IMMUN

Citations per year, relative to Muhammad Tufail Muhammad Tufail (= 1×) peers Tian Ma

Countries citing papers authored by Muhammad Tufail

Since Specialization

Citations

This map shows the geographic impact of Muhammad Tufail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Tufail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Tufail more than expected).

Fields of papers citing papers by Muhammad Tufail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Tufail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Tufail. The network helps show where Muhammad Tufail may publish in the future.

Co-authorship network of co-authors of Muhammad Tufail

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Tufail. A scholar is included among the top collaborators of Muhammad Tufail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Tufail. Muhammad Tufail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tufail, Muhammad, et al.. (2026). The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy. Drug Resistance Updates. 85. 101355–101355.

2.

Tufail, Muhammad. (2025). PTEN-mediated resistance in cancer: From foundation to future therapies. Toxicology Reports. 14. 101987–101987. 4 indexed citations

3.

He, Caiyun, et al.. (2025). Comparative efficacy and safety of cabazitaxel versus other taxanes: a systematic review and meta-analysis. Systematic Reviews. 14(1). 210–210.

4.

Tufail, Muhammad, Canhua Jiang, & Ning Li. (2025). Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence. Military Medical Research. 12(1). 7–7. 16 indexed citations breakdown →

5.

Tufail, Muhammad, Jing Zhang, Caiyun He, et al.. (2025). YY1 lactylation promotes fibroblast senescence by targeting the PU.1-BTG2 axis to promote oral submucous fibrosis. Chemico-Biological Interactions. 421. 111716–111716.

6.

Tufail, Muhammad, Yuqi Huang, Jie Liang, et al.. (2024). Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants. Aging and Disease. 16(3). 0–0. 8 indexed citations

7.

Tufail, Muhammad, Canhua Jiang, & Ning Li. (2024). Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Molecular Cancer. 23(1). 203–203. 161 indexed citations breakdown →

8.

Mahmood, Tariq, Amjad Rehman, Tanzila Saba, et al.. (2024). Enhancing Coronary Artery Disease Prognosis: A Novel Dual-Class Boosted Decision Trees Strategy for Robust Optimization. IEEE Access. 12. 107119–107143. 5 indexed citations

9.

Johnston, Janet, Louise Brown, Matthew Callister, et al.. (2024). What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study. JTO Clinical and Research Reports. 5(8). 100694–100694. 2 indexed citations

10.

Tufail, Muhammad. (2023). Unlocking the potential of the tumor microenvironment for cancer therapy. Pathology - Research and Practice. 251. 154846–154846. 14 indexed citations

11.

Tufail, Muhammad. (2023). DNA repair pathways in breast cancer: from mechanisms to clinical applications. Breast Cancer Research and Treatment. 200(3). 305–321. 9 indexed citations

12.

Tufail, Muhammad. (2023). HOTAIR in colorectal cancer: structure, function, and therapeutic potential. Medical Oncology. 40(9). 259–259. 14 indexed citations

13.

Nadeem, Muhammad, et al.. (2023). Association of Paclitaxel Induced Neuropathy with Quality of Life of Patients with Non-Metastatic Breast Cancer. SHILAP Revista de lepidopterología. 73(3). 755–58. 1 indexed citations

14.

Tufail, Muhammad & Changxin Wu. (2023). WNT5A: a double-edged sword in colorectal cancer progression. Mutation Research/Reviews in Mutation Research. 792. 108465–108465. 14 indexed citations

15.

Tufail, Muhammad & Changxin Wu. (2023). Wnt3a is a promising target in colorectal cancer. Medical Oncology. 40(3). 86–86. 8 indexed citations

16.

Tufail, Muhammad. (2022). Genome editing: An essential technology for cancer treatment. 4. 100015–100015. 7 indexed citations

17.

Tufail, Muhammad, et al.. (2021). Modern day management of a unilateral pleural effusion. Clinical Medicine. 21(6). e561–e566. 3 indexed citations

18.

Tufail, Muhammad, et al.. (2020). Influence of Consanguinity and Medication on the Development of Parkinson’s Disease. Dementia and Geriatric Cognitive Disorders. 49(4). 390–393. 3 indexed citations

19.

Tufail, Muhammad. (2019). Clinical Features and Risk Factors of Parkinson’s Disease in a Population of Khyber Pakhtunkhwa, Pakistan: A Case-Control Study. Neurodegenerative Diseases. 19(5-6). 211–217. 16 indexed citations

20.

Tufail, Muhammad. (2019). A case report of tuberculous empyema: A tricky disease. International Journal of Mycobacteriology. 8(3). 302–302. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact